CD8A and neoplasm: Additionally, alterations in CD3+CD8+ lymphocytes were associated with tumor recurrence status (p = 0.049), with recurrent tumors showing greater increases (19.8% ± 8.89%) than primary tumors (1.48% ± 7.40%).